Trial Profile
An International, Multi-centric, Comparative, Randomized, Parallel group, double-blind, placebo-controlled, phase III clinical trial study to evaluate safety and efficacy of the drug products ReliBeta (Reliance Life Sciences Pvt. Ltd.,India) versus Avonex (Biogen Idec Limited, Great Britain) in the treatment of patients with remitting multiple sclerosis and open after-treatment with Interferon β1а - REAV
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Jul 2019
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors RCI Syntez
- 02 Sep 2016 New trial record